Annual Shareholders Equity
$17.49 M
-$4.52 M-20.54%
June 1, 2024
Summary
- As of February 26, 2025, NEUP annual stockholders equity is $17.49 million, with the most recent change of -$4.52 million (-20.54%) on June 1, 2024.
- During the last 3 years, NEUP annual shareholders equity has fallen by -$18.27 million (-51.09%).
Performance
NEUP Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Shareholders Equity
$13.75 M
-$3.32 M-19.46%
December 1, 2024
Summary
- As of February 26, 2025, NEUP quarterly stockholders equity is $13.75 million, with the most recent change of -$3.32 million (-19.46%) on December 1, 2024.
- Over the past year, NEUP quarterly shareholders equity has stayed the same.
Performance
NEUP Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
NEUP Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -20.5% | 0.0% |
| 3 y3 years | -51.1% | - |
| 5 y5 years | +41.1% | +74.0% |
NEUP Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -55.3% | at low | -68.5% | at low |
| 5 y | 5-year | -55.3% | -50.2% | -68.5% | -42.5% |
| alltime | all time | -58.6% | -102.1% | -68.5% | -73.0% |
Neuphoria Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $13.75 M(-19.5%) |
| Sep 2024 | - | $17.07 M(-2.4%) |
| Jun 2024 | - | $17.49 M(-11.6%) |
| Jun 2024 | $17.49 M(-20.5%) | - |
| Dec 2023 | - | $19.78 M(-10.1%) |
| Jun 2023 | $22.01 M(-43.8%) | $22.01 M(-32.2%) |
| Dec 2022 | - | $32.46 M(-17.1%) |
| Jun 2022 | $39.15 M(+9.5%) | $39.15 M(-10.4%) |
| Dec 2021 | - | $43.70 M(+22.2%) |
| Jun 2021 | $35.76 M(+310.4%) | $35.76 M(+189.3%) |
| Dec 2020 | - | $12.36 M(+41.9%) |
| Jun 2020 | $8.71 M(-29.7%) | $8.71 M(+10.3%) |
| Dec 2019 | - | $7.90 M(-36.2%) |
| Jun 2019 | $12.39 M(-0.5%) | $12.39 M(+5.6%) |
| Dec 2018 | - | $11.74 M(-5.8%) |
| Jun 2018 | $12.46 M(-59.9%) | $12.46 M(-49.3%) |
| Dec 2017 | - | $24.58 M(-20.9%) |
| Jun 2017 | $31.09 M(-1.9%) | $31.09 M(+19.3%) |
| Dec 2016 | - | $26.06 M(-17.8%) |
| Jun 2016 | $31.69 M(+29.2%) | $31.69 M(-11.9%) |
| Dec 2015 | - | $35.97 M(+46.7%) |
| Jun 2015 | $24.52 M(-41.9%) | $24.52 M(-26.0%) |
| Dec 2014 | - | $33.13 M(-21.5%) |
| Jun 2014 | $42.20 M(+11.7%) | $42.20 M(+32.8%) |
| Dec 2013 | - | $31.77 M(-15.9%) |
| Jun 2013 | $37.79 M | $37.79 M(+22.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | - | $30.94 M(+16.7%) |
| Jun 2012 | $26.50 M(-13.6%) | $26.50 M(+2.5%) |
| Dec 2011 | - | $25.85 M(-15.7%) |
| Jun 2011 | $30.67 M(+41.7%) | $30.67 M(+45.2%) |
| Dec 2010 | - | $21.13 M(-2.4%) |
| Jun 2010 | $21.64 M(+43.4%) | $21.64 M(-18.5%) |
| Dec 2009 | - | $26.56 M(+76.1%) |
| Jun 2009 | $15.09 M(-26.7%) | $15.09 M(+20.1%) |
| Dec 2008 | - | $12.57 M(-39.0%) |
| Jun 2008 | $20.60 M(+7.0%) | $20.60 M(+20.6%) |
| Dec 2007 | - | $17.08 M(-11.3%) |
| Jun 2007 | $19.25 M(+137.0%) | $19.25 M(+86.7%) |
| Dec 2006 | - | $10.31 M(+26.9%) |
| Jun 2006 | $8.12 M(-0.2%) | $8.12 M(-16.0%) |
| Dec 2005 | - | $9.67 M(+18.7%) |
| Jun 2005 | $8.14 M(+30.4%) | $8.14 M(+46.4%) |
| Dec 2004 | - | $5.56 M(-11.0%) |
| Jun 2004 | $6.24 M(+38.0%) | $6.24 M(+68.4%) |
| Dec 2003 | - | $3.71 M(-18.1%) |
| Jun 2003 | $4.52 M(-19.5%) | $4.52 M(+6.6%) |
| Dec 2002 | - | $4.25 M(-24.5%) |
| Jun 2002 | $5.62 M(+8.2%) | $5.62 M(-5.6%) |
| Dec 2001 | - | $5.96 M(+14.6%) |
| Jun 2001 | $5.20 M(+72.0%) | $5.20 M(+9.8%) |
| Dec 2000 | - | $4.74 M |
| Jun 2000 | $3.02 M(-930.8%) | - |
| Jun 1999 | -$363.80 K | - |
FAQ
- What is Neuphoria Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Neuphoria Therapeutics?
- What is Neuphoria Therapeutics annual shareholders equity year-on-year change?
- What is Neuphoria Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Neuphoria Therapeutics?
- What is Neuphoria Therapeutics quarterly shareholders equity year-on-year change?
What is Neuphoria Therapeutics annual stockholders equity?
The current annual shareholders equity of NEUP is $17.49 M
What is the all time high annual shareholders equity for Neuphoria Therapeutics?
Neuphoria Therapeutics all-time high annual stockholders equity is $42.20 M
What is Neuphoria Therapeutics annual shareholders equity year-on-year change?
Over the past year, NEUP annual stockholders equity has changed by -$4.52 M (-20.54%)
What is Neuphoria Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of NEUP is $13.75 M
What is the all time high quarterly shareholders equity for Neuphoria Therapeutics?
Neuphoria Therapeutics all-time high quarterly stockholders equity is $43.70 M
What is Neuphoria Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, NEUP quarterly stockholders equity has changed by $0.00 (0.00%)